Care Delivery

This channel includes news on cardiovascular care delivery, including how patients are diagnosed and treated, cardiac care guidelines, policies or legislation impacting patient care, device recalls that may impact patient care, and cardiology practice management.

‘A practice-changing trial’: Semaglutide linked to key benefits for PAD patients with diabetes
Patients who present with type 2 diabetes and PAD often face substantial mobility issues. According to new data presented at ACC.25, however, treatment with semaglutide could represent a major step forward for this high-risk population.
Healthcare AI newswatch: Great expectations for GenAI, disaster-ready AI, Dr. Oz on payer AI, more
Investors are betting on generative AI to solve costly provider workflow inefficiencies. So are provider executives.
When health accessories grow up, they want to be wearable AI
Wearable health gadgets equipped with AI present myriad opportunities and challenges to healthcare consumers and the healthcare professionals who diagnose, treat and track them.
Timing is everything: Delaying noncardiac surgery after a heart procedure reduces risks
When patients require subsequent noncardiac surgery after a major heart operation, waiting at least 100 days is one way to limit the risk of an adverse event. Read the full analysis in JACC: Advances.
Direct marketing to cardiologists increases uptake of some, but not all, heart failure drugs
Researchers tracked three years of CMS data to explore how meal-based marketing may influence the habits of general and advanced heart failure cardiologists.

artificial intelligence AI infrastructure

Industry Watcher’s Digest

New Year’s Day brought the go-live for California’s new law forbidding the use of AI to deny health insurance claims.

FDA AI enabled medical devices approval clearance

FDA to hopeful marketers of AI-equipped medical devices: Think beyond your initial approval

Some FDA-approved medical devices age more safely than others. That’s no less true of AI-enabled technologies than of any others. The agency spells out the ramifications in draft guidance issued this week.

Semaglutide linked to ‘significant and consistent’ benefits for heart bypass surgery patients

The popular GLP-1 receptor agonist appears to help limit adverse events and new-onset diabetes in patients with a history of CABG. Researchers shared the full study in the Journal of the American College of Cardiology.

From left to right: Sunita Ferns, MD; Mark Plunkett, MD; Harma Turbendian, MD. Images courtesy of OSF Healthcare.

History made: Young child treated with new heart device for very first time

A care team in Illinois has performed the first heart procedure of its kind on a two-year-old patient diagnosed with Brugada syndrome.

Industry Watcher’s Digest

Hospital boards of trustees should be grilling their CEOs about AI.

artificial intelligence ai in healthcare

5 healthcare AI predictions for 2025 from Wolters Kluwer Health

Watch for healthcare AI to increase its footprint in the patient-safety domain over the coming year.

infrastructure for AI emerging technologies

Industry Watcher’s Digest

Healthcare AI startups that earn FDA approval are like jobseekers after landing a new job.

artificial intelligence ai in healthcare coding

Industry Watcher’s Digest

Who is Sriram Krishnan, and why is he headed to the White House?

Care Delivery

‘A practice-changing trial’: Semaglutide linked to key benefits for PAD patients with diabetes

Healthcare AI newswatch: Great expectations for GenAI, disaster-ready AI, Dr. Oz on payer AI, more

When health accessories grow up, they want to be wearable AI

Timing is everything: Delaying noncardiac surgery after a heart procedure reduces risks

Direct marketing to cardiologists increases uptake of some, but not all, heart failure drugs